Bleeding risk in 'real world' patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Oral anticoagulation (OAC) in patients with atrial fibrillation (AF) is a double-edged sword, because it decreases the risk of stroke at the cost of an increased risk of bleeding. We compared the performance of a new bleeding prediction scheme, HAS-BLED, with an older bleeding prediction scheme, HEMORR(2)HAGES, in a cohort of 'real-world' AF patients.
OriginalsprogEngelsk
TidsskriftJournal of Thrombosis and Haemostasis
Vol/bind9
Udgave nummer8
Sider (fra-til)1460-7
Antal sider8
ISSN1538-7933
DOI
StatusUdgivet - 1 aug. 2011

ID: 40155679